The infrastructure behind research-grade biobank data.
From initial biobank ingestion to licensed delivery, every step of the Network Bio platform is designed to preserve data integrity, consent chain documentation, and format compatibility.
End-to-end data pipeline with full auditability.
Every stage is documented, quality-checked, and connected to a consent and provenance record — so the chain of custody is never broken.
Four pipeline stages — each with documented output.
Data Ingestion & Normalization
Raw biorepository exports are ingested and normalized to common schemas — clinical data to HL7 FHIR R4, genomic data to VCF, bulk data to Parquet. Field encoding documentation is produced at every ingestion run.
Safe Harbor De-identification
All 18 HIPAA Safe Harbor identifiers are systematically removed or generalized according to defined rules. A de-identification report documents each transformation — designed with HIPAA de-identification standards in mind.
Clinical Phenotype Enrichment
Structured clinical phenotypes, ICD coding, genomic variant annotations, and longitudinal follow-up data are appended to each cohort record — enriching the base biobank data with research-usable clinical context.
Provenance & Consent Ledger
Every dataset delivery includes a provenance ledger: consent audit trail, source biobank reference (de-identified), QC run log, and delivery manifest. This is the documentation package your legal team needs for data room review.
Delivered in the format your pipeline expects.
We don't deliver raw exports and leave the normalization work to you. Every dataset arrives in your requested format, fully schema-documented, with a data dictionary and field encoding guide.
Typical delivery timeline
Ready to see what's in our catalog?
Browse available datasets by therapeutic area, or submit a data brief and we'll find the right cohort for your program.